Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

happy_doctor

Illegal psilocybin shows promise in treatment of depression

December 1, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johns Hopkins, Magic mushrooms, psilocybin

A double-blind study of psilocybin, the hallucinogenic drug chemical found in ‘magic mushrooms’,  has been found to have substantial mental …
News
blood-75302_640

Researchers develop capsule-based haemophilia treatment tech

November 30, 2016 Research and Development University of Texas, haemophilia

Researchers at the University of Texas have developed a new method for treating haemophilia B which utilises a biodegradable oral …
News

Teva to shut down Maltese plant, axe 210 jobs

November 30, 2016 Manufacturing and Production, Research and Development Actavis Generics, Allergan, Malta, Teva

Teva is set to axe 210 jobs and shut down a production plant in Malta in an effort to cut …
News
advanced_manufacturing_building_site_uon

£25m flagship manufacturing & research facility for University of Nottingham

November 30, 2016 Manufacturing and Production, Research and Development University of Nottingham

Earlier this month, the University of Nottingham began work on a ‘pioneering’ Advanced Manufacturing Building. The £25 million, 9,011 square-metre …
News
humira_abbott_

Humira biosimilar proves efficacy in Phase 3 trial

November 30, 2016 Research and Development AbbVie, Amgen, FDA, Humira, M923, Momenta

US-based biotechnology firm Momenta Pharmaceuticals has announced that its biosimilar version of Abbvie’s autoimmune drug Humira (adalimumab) – currently the …
News
shutterstock_204190579

MDMA trials get FDA backing for PTSD treatment

November 30, 2016 Research and Development FDA, MDMA, PTSD

The FDA have given the go-ahead to Phase 3 clinical trials investigating the efficacy of MDMA (Methylenedioxymethamphetamine) for treating post-traumatic …
News
actinium_pharma

Actinium snatches up ex-Novartis clinical manager

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actinium, Novartis, appointment

Actinium Pharmaceuticals has appointed Gregory Bergonio to the position of director of Clinical Operations, where he will first guide the …
Appointment

NICE recommends 4p breast cancer drug for healthy women

November 29, 2016 Research and Development, Sales and Marketing NICE, anastrozole, breast cancer

NICE has published new draft guidance calling for women with a strong family history of breast cancer to be offered …
News
ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …
Appointment

PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider

November 29, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …
News
Press release
cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
News

FDA orphan drug designation doubles PhaseRx shares

November 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx

PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
News
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
Feature
syqe-marijuana_inhaler

Teva to market world’s first medical marijuana inhaler

November 28, 2016 Research and Development, Sales and Marketing

Israel’s Teva Pharmaceutical Industries has signed an agreement with Tel Aviv-based biotech Syqe Medical for the distribution and marketing of …
News
uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026